Experienced in Primary Lymphoma of the Brain

Dr. Wyndham H. Wilson

Oncology

Bethesda, MD

Clinical Trials:Currently Recruiting for 2 Trials

44 Years of Experience

Experienced in Primary Lymphoma of the Brain

Bethesda, MD

OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Wyndham Wilson is an Oncologist in Bethesda, Maryland. Dr. Wilson has been practicing medicine for over 44 years and is rated as an Experienced provider by MediFind in the treatment of Primary Lymphoma of the Brain. His top areas of expertise are B-Cell Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Burkitt Lymphoma.

His clinical research consists of co-authoring 167 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Primary Lymphoma of the Brain.

Specialties

Oncology

Licenses

Internal Medicine in WV

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance

Find your insuranceClose

Locations

Bethesda, MD 20892

Call: 301-435-2415

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Phase 1b/2 Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

Enrollment Status: Recruiting

Publish Date: October 07, 2025

Intervention Type: Drug, Biological

Study Drugs: Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, Revlimid

Study Phase: Phase 1/Phase 2

Lymphoid Malignancies and Precursors: Tissue Acquisition Protocol

Enrollment Status: Recruiting

Publish Date: September 30, 2025

Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Adults and Children With Previously Untreated Patients With Aggressive Non-Hodgkin's Lymphoma

Enrollment Status: Completed

Publish Date: June 22, 2025

Intervention Type: Diagnostic test, Drug, Other, Procedure, Biological

Study Drugs: EPOCH, Rituximab

Study Phase: Phase 2

Treatment and Natural History Study of Lymphomatoid Granulomatosis

Enrollment Status: Completed

Publish Date: June 19, 2025

Intervention Type: Biological, Diagnostic test, Drug, Procedure

Study Drugs: IFN-Alpha, Rituximab, EPOCH

Study Phase: Phase 2

Safety and Feasibility of Stem Cell Gene Transfer Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patients Using Peripheral Blood Stem/Progenitor Cells Treated With a Lentivirus Vector-Encoding Multiple Anti-HIV RNAs

Enrollment Status: Active_not_recruiting

Publish Date: February 06, 2025

Intervention Type: Drug, Biological

Study Drugs: Prednisone, Rituximab, Etoposide, Doxorubicin Hydrochloride, Vincristine Sulfate, Cyclophosphamide, Filgrastim, Lentivirus Vector rHIV7-shI-TAR-CCR5RZ-transduced Hematopoietic Stem/Progenitor Cells

Study Phase: Phase 1

Short-Course EPOCH - Rituximab in Untreated CD-20+ HIV-Associated Lymphomas

Enrollment Status: Completed

Publish Date: September 04, 2024

Intervention Type: Drug, Biological

Study Drugs: Rituximab, filgrastim, EPOCH

Study Phase: Phase 2

A Phase 2 Multicenter, Investigator Initiated Study of Oral Ruxolitinib Phosphate for the Treatment of Relapsed or Refractory Diffuse Large B-Cell and Peripheral T-Cell Non-Hodgkin Lymphoma

Enrollment Status: Completed

Publish Date: October 05, 2023

Intervention Type: Drug, Other

Study Drug: Ruxolitinib Phosphate

Study Phase: Phase 2

Pilot Study of Idiotype Vaccine and EPOCH-Rituximab Chemotherapy in Untreated Mantle Cell Lymphoma

Enrollment Status: Completed

Publish Date: January 31, 2023

Intervention Type: Biological, Drug

Study Drugs: EPOCH-R, GM-CSF, Idiotype Vaccine

Study Phase: Phase 2

View 6 Less Clinical Trials

172 Total Publications

The anti-CD47 antibody magrolimab with obinutuzumab and venetoclax in relapsed or refractory indolent B-cell lymphomas.

Journal: British journal of haematology

Published: March 28, 2025

View All 172 Publications

Similar Doctors

Distinguished in Primary Lymphoma of the Brain

Dr. Matthias Holdhoff

Oncology

Distinguished in Primary Lymphoma of the Brain

Dr. Matthias Holdhoff

Oncology

Johns Hopkins University

600 N Wolf St,

Baltimore, MD

(34.9 miles away)

410-955-5000

Languages Spoken:

English

See accepted insurances

Offers Telehealth

Matthias Holdhoff is an Oncologist in Baltimore, Maryland. Dr. Holdhoff is rated as an Elite provider by MediFind in the treatment of Primary Lymphoma of the Brain. His top areas of expertise are Glioma, Glioblastoma, Astrocytoma, and Brain Tumor.

Distinguished in Primary Lymphoma of the Brain

Dr. Myo K. Min

Hematology Oncology | Hematology | Oncology

Distinguished in Primary Lymphoma of the Brain

Dr. Myo K. Min

Hematology Oncology | Hematology | Oncology

Upper Chesapeake Hematology And Oncology Services, LLC

9114 Philadelphia Rd, Suite 208,

Baltimore, MD

(42.1 miles away)

410-687-5300

Languages Spoken:

English, Burmese

See accepted insurances

Accepting New Patients

Offers Telehealth

Myo Min is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Min is rated as a Distinguished provider by MediFind in the treatment of Primary Lymphoma of the Brain. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Colorectal Cancer, and Large-Cell Immunoblastic Lymphoma. Dr. Min is currently accepting new patients.

Advanced in Primary Lymphoma of the Brain

Dr. Danielle A. Shafer

Oncology | Hematology | Hematology Oncology

Advanced in Primary Lymphoma of the Brain

Dr. Danielle A. Shafer

Oncology | Hematology | Hematology Oncology

Inova Health Care Services

3300 Gallows Rd,

Falls Church, VA

(11.0 miles away)

Languages Spoken:

English

See accepted insurances

Accepting New Patients

Offers Telehealth

Danielle Shafer is an Oncologist and a Hematologist in Falls Church, Virginia. Dr. Shafer is rated as a Distinguished provider by MediFind in the treatment of Primary Lymphoma of the Brain. Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Aspiration, and Myringotomy. Dr. Shafer is currently accepting new patients.

VIEW MORE PRIMARY LYMPHOMA OF THE BRAIN DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wilson's expertise for a condition

ConditionClose